The BJP has endorsed the NCERT's move to include the Emergency period in Class 9 textbooks, deeming it a crucial "dark chapter" for student...

Global markets are gaining traction as geopolitical worries ease and AI companies report strong earnings. Matt Orton of Raymond James highl...

New-age Indian brands are rapidly outperforming established FMCG companies, growing over three times faster and reshaping various consumer ...

Retailers are urging the government to intensify efforts against illegal trade and fake products, citing risks to consumer safety and the l...

A recent study reveals that taking a five-minute walking break every hour is the sweet spot for combating the health risks of prolonged sit...

Bodycraft Clinic and Salon has secured Rs 120 crore funding from Singularity AMC to fuel its expansion across India. The integrated beauty,...

South Korea remains in the emerging-market category as MSCI cites persistent foreign exchange market accessibility issues. Despite ongoing ...

Investors are increasingly backing India's beauty and personal care manufacturing sector, moving beyond consumer brands. Companies like Nat...

Veteran strategist Ed Yardeni views the recent rise in Treasury yields and the AI stock correction as healthy market adjustments, not crisi...

India's beauty and personal care market is set for a significant surge, projected to hit $39 billion by 2030. Flipkart's report reveals a s...

Yoga offers significant benefits for male fertility. A 12-week yoga program improved sperm quality and reduced oxidative stress and DNA dam...

India's latest health survey reveals significant improvements in maternal care and child vaccination rates. Stunting among children has see...

Cipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...